N@N

AEE, AGN, CHK, BCR, CERN, DOV Expected to Trade Up Short Term

June 7, 2011 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring top equities trading strategies and these stocks are the most likely to trade Up in the coming weeks. AMEREN CORPORATION (NYSE:AEE), ALLERGAN INC (NYSE:AGN), CHESAPEAKE ENERGY CORP (NYSE:CHK), C.R. BARD INC (NYSE:BCR), CERNER CORP (NASDAQ:CERN), DOVER CORP (NYSE:DOV) are all expected to go Up as Bullish signals have been generated by top equity trading strategies. This trading system is designed to identify high probability reversion to mean trading candidates. It looks to go long immediately following strong sell-offs, and goes short after sharp run ups. Its trades are short term and hone in on the irrational decisions of emotional traders around these extreme moves. The specific technology used to make these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/sw/ot.php The chart below displays the stocks expected to go Up and a suggested stop level to limit any potential trading losses.

     Symbol     Company                             Price          Price Stop Level
     AEE        AMEREN CORPORATION                  28.650         $0.87     
     AGN        ALLERGAN INC                        79.740         $75.83    
     CHK        CHESAPEAKE ENERGY CORP              29.680         $27.72    
     BCR        C.R. BARD INC                       107.930        $103.71   
     CERN       CERNER CORP                         117.160        $5.29     
     DOV        DOVER CORP                          62.180         $57.54    

AMEREN CORPORATION (NYSE:AEE) - Ameren Corporation, through its subsidiaries, operates as a public utility holding company in Missouri and Illinois. It engages in the rate-regulated electric generation, transmission, and distribution businesses; rate-regulated natural gas transmission and distribution businesses; and merchant generation businesses. The company was founded in 1881 and is headquartered in St. Louis, Missouri.

ALLERGAN INC (NYSE:AGN) - Allergan, Inc. operates as a multi-specialty healthcare company primarily in the United States, Europe, Latin America, and the Asia Pacific. The company discovers, develops, and commercializes specialty pharmaceutical, biologics, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatological, breast aesthetics, obesity intervention, urological, and other specialty markets worldwide. It operates in two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment produces a range of pharmaceutical products, including ophthalmic products for chronic dry eye, glaucoma, retinal diseases, and ocular surface disease; Botox for certain therapeutic and aesthetic indications; skin care products for acne, psoriasis, and eyelash growth, as well as other prescription and over-the-counter skin care products; and urologics products. The Medical Devices segment offers a range of medical devices, such as breast implants for augmentation, revision, and reconstructive surgery; obesity intervention products comprising the Lap-Band System and the Orbera Intragastric Balloon System; and facial aesthetics products. The company sells its products to drug wholesalers, independent and chain drug stores, pharmacies, commercial optical chains, opticians, mass merchandisers, food stores, hospitals, group purchasing organizations, integrated direct hospital networks, and ambulatory surgery centers, as well as to medical practitioners, including ophthalmologists, neurologists, physiatrists, dermatologists, plastic and reconstructive surgeons, aesthetic specialty physicians, bariatric surgeons, pediatricians, urologists, and general practitioners. It has strategic research collaboration agreements with ExonHit Therapeutics S.A.; Spectrum Pharmaceuticals, Inc.; Pieris AG; and ACADIA Pharmaceuticals Inc. The company was founded in 1948 and is headquartered in Irvine, California.

CHESAPEAKE ENERGY CORP (NYSE:CHK) - Chesapeake Energy Corporation, together with its subsidiaries, produces natural gas in the United States. The company focuses on discovering, acquiring, and developing conventional and unconventional natural gas reserves onshore in the United States, primarily in its six natural gas shale plays: the Barnett Shale in the Fort Worth Basin of north-central Texas; the Haynesville and Bossier Shales in the Ark-La-Tex area of northwestern Louisiana and east Texas; the Fayetteville Shale in the Arkoma Basin of central Arkansas; the Marcellus Shale in the northern Appalachian Basin of West Virginia, Pennsylvania; and New York and the Eagle Ford Shale in south Texas. It also has operations in the Granite Wash Plays of western Oklahoma and the Texas Panhandle regions, as well as various other plays, both conventional and unconventional, in the Mid-Continent, Appalachian Basin, Permian Basin, Delaware Basin, south Texas, Texas Gulf Coast and Ark-La-Tex regions. As of December 31, 2009, the company owned interests in approximately 44,100 productive wells; and had proved reserves of 14.254 (22,900 net) trillion cubic feet of natural gas equivalent. The company was founded in 1989 and is based in Oklahoma City, Oklahoma.

C.R. BARD INC (NYSE:BCR) - C. R. Bard, Inc., together with its subsidiaries, engages in the design, manufacture, packaging, distribution, and sale of medical, surgical, diagnostic, and patient care devices worldwide. It offers vascular, urology, oncology, and surgical specialty products. The companys vascular products include percutaneous transluminal angioplasty catheters, guidewires, introducers, and accessories; peripheral vascular stents and stent grafts, vena cava filters, and biopsy devices; electrophysiology products, such as electrophysiology diagnostic, therapeutic, and temporary pacing electrode catheters, as well as laboratory systems; and fabrics, meshes, and implantable vascular grafts. Its urology products comprise infection control Foley catheters to reduce the rate of urinary tract infections; surgical slings used to treat stress urinary incontinence; natural and synthetic devices to treat pelvic floor and vaginal prolapse; brachytherapy services, devices, and radioactive seeds used to treat prostate cancer; intermittent urinary drainage catheters, and urine monitoring and collection systems; ureteral stents; specialty devices for ureteroscopic procedures and stone removal; fecal incontinence products; and catheter stabilization devices. The company offers various devices to treat and manage cancers, and other diseases and disorders, including specialty access catheters, ports, vascular access ultrasound devices, and enteral feeding devices. Its surgical specialty products include implanted patches and fixation systems for hernia and other soft tissue repairs; irrigation devices for orthopedic, laparoscopic, and gynecological procedures; and products for topical hemostasis. C. R. Bard sells its products directly and through distributors to hospitals, individual health care professionals, extended care facilities, and alternate site facilities. The company was founded in 1907 and is based in Murray Hill, New Jersey.

CERNER CORP (NASDAQ:CERN) - Cerner Corporation provides healthcare information technology, healthcare devices, and content solutions for healthcare organizations and consumers in the Americas, Europe, the Middle East, and the Asia Pacific region. It offers Cerner Millennium architecture, which provides access to an individuals electronic medical record at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front and back-office professionals, and consumers. The company also provides a range of services, including implementation and training, remote hosting, operational management services, revenue cycle services, support and maintenance, healthcare data analysis, clinical process optimization, transaction processing, employer health centers, employee wellness programs, and third party administrator services for employer-based health plans. It serves integrated delivery networks, physician groups and networks, managed care organizations, hospitals, medical centers, reference laboratories, home health agencies, blood banks, imaging centers, pharmacies, government agencies, employers, governments, and public health organizations. The company was founded in 1979 and is headquartered in North Kansas City, Missouri.

DOVER CORP (NYSE:DOV) - Dover Corporation and its subsidiaries manufacture industrial products and components, as well as provide related services and consumables in the United States and internationally. The company operates through four segments: Industrial Products, Engineered Systems, Fluid Management, and Electronic Technologies. The Industrial Products segment develops and manufactures material handling equipment, such as industrial and recreational winches; utility, construction, and demolition machinery attachments; hydraulic parts; industrial automation tools; four-wheel-drive and all-wheel drive powertrain systems; and other accessories for off-road vehicles. It also offers mobile equipment related products, including refuse truck bodies, tank trailers, compactors, balers, vehicle service lifts, car wash systems, internal engine components, fluid control assemblies, and various aerospace components. The Engineered Systems segment provides products and services for the refrigeration, storage, packaging, and preparation of food products, as well as industrial marking and coding systems for various markets. The Fluid Management segment manufactures polycrystalline diamond cutters used in drill bits for oil and gas wells; steel sucker rods, plunger lifts, and accessories used in artificial lift applications in oil and gas production; pressure, temperature, and flow monitoring equipment used in oil and gas exploration and production applications; and control valves and instrumentation for oil and gas production. This segment also manufactures pumps, compressors, and vehicle fuel dispensing products; and products for the transfer, monitoring, measuring, and protection of hazardous, liquid, and dry bulk commodities. The Electronic Technologies segment designs and manufactures electronic test, material deposition and manual soldering equipment, micro-acoustic components, and specialty electronic components. The company was founded in 1947 and is headquartered in Downers Grove, Illinois.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net